These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24228263)

  • 21. Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients.
    Wu T; Zheng X; Yang M; Zhao A; Li M; Chen T; Panee J; Jia W; Ji G
    Sci Rep; 2017 Feb; 7():42710. PubMed ID: 28198443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma.
    Huang MJ; Liaw YF
    Am J Gastroenterol; 1990 Mar; 85(3):281-4. PubMed ID: 1689951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
    Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
    Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry.
    Liu Y; Sogawa K; Sunaga M; Umemura H; Satoh M; Kazami T; Yoshikawa M; Tomonaga T; Yokosuka O; Nomura F
    Am J Clin Pathol; 2014 Jan; 141(1):52-61. PubMed ID: 24343737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus].
    Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen CY
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):74-5. PubMed ID: 18226355
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
    Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid serum profile in patients with viral liver cirrhosis.
    Vere CC; Streba CT; Streba L; Rogoveanu I
    Med Princ Pract; 2012; 21(6):566-8. PubMed ID: 22722340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
    Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
    Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.
    Lian JS; Liu W; Hao SR; Guo YZ; Huang HJ; Chen DY; Xie Q; Pan XP; Xu W; Yuan WX; Li LJ; Huang JR
    Chin Med J (Engl); 2011 May; 124(9):1367-73. PubMed ID: 21740750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
    Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
    Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study.
    Thumanu K; Sangrajrang S; Khuhaprema T; Kalalak A; Tanthanuch W; Pongpiachan S; Heraud P
    J Biophotonics; 2014 Apr; 7(3-4):222-31. PubMed ID: 24639420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
    Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M
    Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
    Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
    Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases.
    Lin CC; Huang JF; Tsai LY; Huang YL
    Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.